HCPCS Level II › M codes › M0244

M0244

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency

TerminatedHCPCS Level II code.

Still listed by CMS but carries a termination date, so it is not valid for a current date of service.

Terminated with effect from 2024-12-12. First published 2023. CMS still lists this code in the current quarterly file - it carries a termination date rather than being removed.

What has happened to this code

Every change the publisher made, from 2025 to now.

  1. April 2025 Terminated by CMS